Stifel analysts initiated coverage on Cytokinetics shares (NASDAQ:CYTK), assigning a Buy rating and setting a price target of ...
Stifel initiated coverage of Cytokinetics (CYTK) with a Buy rating and $80 price target Cytokinetics “is an out-of-favor stock” following the ...
Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.
Wall Street analysts are buzzing with optimism as we step into 2025.  There are plenty of reasons for a positive view to ...
Stifel initiated coverage of Edgewise Therapeutics (EWTX) with a Hold rating and $30 price target The firm says that while Edgewise has “very ...
Altimmune Inc (ALT) stock saw a modest uptick, ending the day at $6.86 which represents a slight increase of $0.15 or 2.24% from the prior close of $6.71. The stock opened at $6.8 and touched a low of ...
Brian Gardner, Stifel chief Washington policy strategist, joins 'Closing Bell Overtime' to talk how to play the Trump trade ...
Stifel downgrades cybersecurity stocks Rapid7 and Tenable to Hold, citing cautious stance on vulnerability management.
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.74% of ...
Alpaca Real Estate (“ARE”), an alternative investment management firm, closed a $50 million credit facility with Stifel Bank. This financing marks another key milestone in the firm’s growth, ...
Stifel initiated coverage of FanDuel parent company Flutter Thursday with a $320 target price and a buy rating.
Stifel analysts revised their price target for FTAI Aviation (NASDAQ:FTAI) shares, lowering it significantly to $100 from the ...